Genewise Bio
Beijing
About Genewise Bio
Genewise Bio is a biotechnology company that specializes in the technological iteration of POCT in molecular diagnostics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $14.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2024)
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/genewise-bio-129711 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.